Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07782554 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07782554 · ClinicalTrials.gov record · last posted 2026-08-24

EUS-Guided Portal Pressure Gradient Measurement in Prehepatic Portal Hypertension

StatusCompleted
PhaseNot specified
Started2025-03-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Portal hypertension caused by prehepatic vascular obstruction, such as portal vein thrombosis or portal vein tumor thrombosis, represents a unique hemodynamic condition in which conventional hepatic venous pressure gradient (HVPG) measurement may not accurately reflect portal venous pressure. Endoscopic ultrasound-guided portal pressure gradient (EUS-PPG) measurement provides a direct approach for assessing portal hemodynamics. This retrospective observational study included patients with cirrhosis and esophagogastric varices complicated by portal vein thrombosis or portal vein tumor thrombosis. All patients underwent abdominal computed tomography to confirm the presence of portal vein obstruction, liver stiffness measurement by ultrasound elastography, HVPG measurement, and EUS-PPG measurement. The study aims to evaluate the relationship between EUS-PPG and HVPG and to explore the associations between portal pressure measurements and clinical characteristics, including underlying liver disease etiology, liver function grade, sex, gastrointestinal bleeding, and hepatic encephalopathy.
Trial Details
NCT Number NCT07782554
Lead Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions Prehepatic Portal Hypertension
Enrollment 59 participants
Start Date 2025-03-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-24